The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

MLA

Walker, Adrian B., et al. “The Thiazolidinedione Rosiglitazone (BRL-49653) Lowers Blood Pressure and Protects against Impairment of Endothelial Function in Zucker Fatty Rats.” Diabetes, vol. 48, no. 7, July 1999, pp. 1448–53. EBSCOhost, https://doi.org/10.2337/diabetes.48.7.1448.

APA

Walker, A. B., Chattington, P. D., Buckingham, R. E., Williams, G., Walker, A. B., Chattington, P. D., Buckingham, R. E., & Williams, G. (1999). The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Diabetes, 48(7), 1448–1453. https://doi.org/10.2337/diabetes.48.7.1448

Chicago

Walker, Adrian B., Paula D. Chattington, Robin E. Buckingham, Gareth Williams, A B Walker, P D Chattington, R E Buckingham, and G Williams. 1999. “The Thiazolidinedione Rosiglitazone (BRL-49653) Lowers Blood Pressure and Protects against Impairment of Endothelial Function in Zucker Fatty Rats.” Diabetes 48 (7): 1448–53. doi:10.2337/diabetes.48.7.1448.